Trials / Conditions / Stage III Uterine Sarcoma

Stage III Uterine Sarcoma

11 registered clinical trials studyying Stage III Uterine Sarcoma.

Status	Trial	Sponsor	Phase
Completed	Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer NCT01764802	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa NCT01098630	Gynecologic Oncology Group	—
Completed	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258	University of Southern California	Phase 1
Completed	Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery NCT01553539	Wake Forest University Health Sciences	Phase 2
Completed	Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan NCT01079832	Case Comprehensive Cancer Center	Phase 2
Completed	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma NCT00659360	National Cancer Institute (NCI)	Phase 2
Completed	Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu NCT00390234	National Cancer Institute (NCI)	Phase 2
Completed	Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma NCT00245102	National Cancer Institute (NCI)	Phase 2
Completed	Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer NCT00238121	National Cancer Institute (NCI)	Phase 2
Terminated	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191	National Cancer Institute (NCI)	N/A